FSDC vs. KRRO, VRCA, STTK, NGNE, TERN, ESPR, ANRO, MREO, ORGO, and HRTX
Should you be buying FS Development stock or one of its competitors? The main competitors of FS Development include Korro Bio (KRRO), Verrica Pharmaceuticals (VRCA), Shattuck Labs (STTK), Neurogene (NGNE), Terns Pharmaceuticals (TERN), Esperion Therapeutics (ESPR), Alto Neuroscience (ANRO), Mereo BioPharma Group (MREO), Organogenesis (ORGO), and Heron Therapeutics (HRTX). These companies are all part of the "medical" sector.
FS Development (NASDAQ:FSDC) and Korro Bio (NASDAQ:KRRO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment, community ranking and earnings.
FS Development's return on equity of 0.00% beat Korro Bio's return on equity.
Korro Bio has a consensus target price of $122.50, suggesting a potential upside of 124.11%. Given Korro Bio's higher probable upside, analysts plainly believe Korro Bio is more favorable than FS Development.
FS Development has higher earnings, but lower revenue than Korro Bio.
89.8% of FS Development shares are owned by institutional investors. Comparatively, 13.2% of Korro Bio shares are owned by institutional investors. 16.8% of Korro Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, Korro Bio had 19 more articles in the media than FS Development. MarketBeat recorded 19 mentions for Korro Bio and 0 mentions for FS Development. Korro Bio's average media sentiment score of 0.28 beat FS Development's score of 0.00 indicating that Korro Bio is being referred to more favorably in the news media.
Korro Bio received 11 more outperform votes than FS Development when rated by MarketBeat users.
Summary
Korro Bio beats FS Development on 7 of the 10 factors compared between the two stocks.
Get FS Development News Delivered to You Automatically
Sign up to receive the latest news and ratings for FSDC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FSDC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
FS Development Competitors List
Related Companies and Tools
